{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T00:34:30Z","timestamp":1648600470511},"reference-count":52,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina Cl\u00ednica"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1016\/j.medcli.2010.09.008","type":"journal-article","created":{"date-parts":[[2010,11,9]],"date-time":"2010-11-09T07:49:24Z","timestamp":1289288964000},"page":"408-413","source":"Crossref","is-referenced-by-count":1,"title":["Inmunodiagn\u00f3stico y biomarcadores en tuberculosis"],"prefix":"10.1016","volume":"137","author":[{"given":"Heinner","family":"Guio","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Vilaplana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pere-Joan","family":"Cardona","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.medcli.2010.09.008_bib0005","unstructured":"World Health Organization. Global Tuberculosis Control: Epidemiology, strategy, financing. WHO report 2009."},{"key":"10.1016\/j.medcli.2010.09.008_bib0010","unstructured":"Diagnostic Standards and Classification of Tuberculosis in Adults and Children. This official statement of the American Thoracic Society and the Centers for Disease Control and Prevention was adopted by the ATS Board of Directors, July 1999. This statement was endorsed by the Council of the Infectious Disease Society of America, September 1999. Am. J. Respir. Crit. Care Med. 2000;161:1376\u201395."},{"key":"10.1016\/j.medcli.2010.09.008_bib0015","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1164\/rccm.200901-0059OC","article-title":"Increasing proportions of advanced pulmonary tuberculosis reported in the United States: are delays in diagnosis on the rise?","volume":"180","author":"Wallace","year":"2009","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.medcli.2010.09.008_bib0020","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1128\/AAC.00749-08","article-title":"New drugs against tuberculosis: problems, progress, and evaluation of agents in clinical development","volume":"53","author":"Van den Boogaard","year":"2009","journal-title":"Antimicrob Agents Chemother."},{"key":"10.1016\/j.medcli.2010.09.008_bib0025","first-page":"489","article-title":"Working alliance for TB drug development, Cape Town, South Africa, February 8th, 2000","volume":"4","author":"Pablos-Mendez","year":"2000","journal-title":"Int J Tuberc Lung Dis."},{"key":"10.1016\/j.medcli.2010.09.008_bib0030","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1086\/647944","article-title":"4 months of rifampin compared with 9 months of isoniazid for the management of latent tuberculosis infection: a meta-analysis and cost-effectiveness study that focuses on compliance and liver toxicity","volume":"49","author":"Ziakas","year":"2009","journal-title":"Clin Infect Dis."},{"key":"10.1016\/j.medcli.2010.09.008_bib0035","doi-asserted-by":"crossref","unstructured":"Cardona PJ. RUTI: a new chance to shorten the treatment of latent tuberculosis infection. Tuberculosis (Edinburgh, Scotland). 2006 l;86:273\u201389.","DOI":"10.1016\/j.tube.2006.01.024"},{"key":"10.1016\/j.medcli.2010.09.008_bib0040","first-page":"589","article-title":"The latent tuberculosis bacillus (I\u2019ll let you know if I ever meet one)","volume":"5","author":"Orme","year":"2001","journal-title":"Int J Tuberc Lung Dis."},{"key":"10.1016\/j.medcli.2010.09.008_bib0045","first-page":"845","article-title":"The spectrum of latent tuberculosis: rethinking the biology and intervention strategies","volume":"7","author":"Barry","year":"2009","journal-title":"Nature reviews."},{"key":"10.1016\/j.medcli.2010.09.008_bib0050","unstructured":"Efficacy of various durations of isoniazid preventive therapy for tuberculosis: five years of follow-up in the IUAT trial. International Union Against Tuberculosis Committee on Prophylaxis. Bulletin of the World Health Organization. 1982;60:555\u201364."},{"key":"10.1016\/j.medcli.2010.09.008_bib0055","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1007\/s15010-008-8087-y","article-title":"A dynamic reinfection hypothesis of latent tuberculosis infection","volume":"37","author":"Cardona","year":"2009","journal-title":"Infection."},{"key":"10.1016\/j.medcli.2010.09.008_bib0060","doi-asserted-by":"crossref","first-page":"e1502","DOI":"10.1371\/journal.pone.0001502","article-title":"The enduring hypoxic response of Mycobacterium tuberculosis","volume":"3","author":"Rustad","year":"2008","journal-title":"PloS one."},{"key":"10.1016\/j.medcli.2010.09.008_bib0065","doi-asserted-by":"crossref","first-page":"e5590","DOI":"10.1371\/journal.pone.0005590","article-title":"Identification of T-cell antigens specific for latent Mycobacterium tuberculosis infection","volume":"4","author":"Schuck","year":"2009","journal-title":"PloS one."},{"key":"10.1016\/j.medcli.2010.09.008_bib0070","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1016\/j.vaccine.2004.09.008","article-title":"Immunotherapy with fragmented Mycobacterium tuberculosis cells increases the effectiveness of chemotherapy against a chronical infection in a murine model of tuberculosis","volume":"23","author":"Cardona","year":"2005","journal-title":"Vaccine."},{"key":"10.1016\/j.medcli.2010.09.008_bib0075","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1093\/clinids\/17.6.968","article-title":"The tuberculin skin test","volume":"17","author":"Huebner","year":"1993","journal-title":"Clin Infect Dis."},{"key":"10.1016\/j.medcli.2010.09.008_bib0080","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1164\/rccm.200811-1704OC","article-title":"Within-subject variability and boosting of T-cell interferon-gamma responses after tuberculin skin testing","volume":"180","author":"Van Zyl-Smit","year":"2009","journal-title":"Am J Respir Crit Care Med."},{"key":"10.1016\/j.medcli.2010.09.008_bib0085","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.ccm.2009.08.016","article-title":"Novel and improved technologies for tuberculosis diagnosis: progress and challenges","volume":"30","author":"Pai","year":"2009","journal-title":"Clin Chest Med."},{"key":"10.1016\/j.medcli.2010.09.008_bib0090","first-page":"49","article-title":"Guidelines for using the QuantiFERON-TB Gold test for detecting Mycobacterium tuberculosis infection, United States","volume":"54","author":"Mazurek","year":"2005","journal-title":"MMWR Recomm Rep."},{"key":"10.1016\/j.medcli.2010.09.008_bib0095","unstructured":"Royal College of Physicians. Tuberculosis: national clinical guidelines for diagnosis, management, prevention, and control. London: Royal College of Physicians;2006. Acceso: www.nice.org.uk.[\u00daltima fecha de consulta 31-8-10]."},{"key":"10.1016\/j.medcli.2010.09.008_bib0100","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1157\/13126836","article-title":"Diagnostico y tratamiento de la tuberculosis","volume":"44","author":"Ruiz-Manzano","year":"2008","journal-title":"Arch Bronconeumol."},{"key":"10.1016\/j.medcli.2010.09.008_bib0105","doi-asserted-by":"crossref","first-page":"177","DOI":"10.7326\/0003-4819-149-3-200808050-00241","article-title":"Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update","volume":"149","author":"Pai","year":"2008","journal-title":"Ann Intern Med."},{"key":"10.1016\/j.medcli.2010.09.008_bib0110","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1097\/MCP.0b013e32832a0adc","article-title":"T-cell interferon-gamma release assays for the rapid immunodiagnosis of tuberculosis: clinical utility in high-burden vs. low-burden settings","volume":"15","author":"Dheda","year":"2009","journal-title":"Curr Opin Pul Med."},{"key":"10.1016\/j.medcli.2010.09.008_bib0115","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1164\/rccm.200904-0557OC","article-title":"Bronchoalveolar lavage enzyme-linked immunospot for a rapid diagnosis of tuberculosis: a Tuberculosis Network European Trialsgroup study","volume":"180","author":"Jafari","year":"2009","journal-title":"Am J Respir Crit Care Med."},{"key":"10.1016\/j.medcli.2010.09.008_bib0120","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1086\/518234","article-title":"Clinical, immunological, and epidemiological importance of antituberculosis T cell responses in HIV-infected Africans","volume":"44","author":"Rangaka","year":"2007","journal-title":"Clin Infect Dis."},{"key":"10.1016\/j.medcli.2010.09.008_bib0125","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1097\/QAD.0b013e3283188415","article-title":"Comparing QuantiFERON-tuberculosis gold, T-SPOT tuberculosis and tuberculin skin test in HIV-infected individuals from a low prevalence tuberculosis country","volume":"22","author":"Stephan","year":"2008","journal-title":"AIDS (London, England)."},{"key":"10.1016\/j.medcli.2010.09.008_bib0130","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.eimc.2009.05.012","article-title":"Determinaciones de la liberaci\u00f3n de interfer\u00f3n gamma: principios y pr\u00e1ctica","volume":"28","author":"Lalvani","year":"2010","journal-title":"Enferm Infecc Microbiol Clin."},{"key":"10.1016\/j.medcli.2010.09.008_bib0135","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1128\/CVI.00132-07","article-title":"Discrepancy between Mycobacterium tuberculosis-specific gamma interferon release assays using short and prolonged in vitro incubation","volume":"14","author":"Leyten","year":"2007","journal-title":"Clin Vaccine Immunol."},{"key":"10.1016\/j.medcli.2010.09.008_bib0140","doi-asserted-by":"crossref","first-page":"3221","DOI":"10.1128\/IAI.01677-07","article-title":"Effect of multiple genetic polymorphisms on antigen presentation and susceptibility to Mycobacterium tuberculosis infection","volume":"76","author":"Chang","year":"2008","journal-title":"Infect Immun."},{"key":"10.1016\/j.medcli.2010.09.008_bib0145","first-page":"726","article-title":"Selective increases in antibody isotypes and immunoglobulin G subclass responses to secreted antigens in tuberculosis patients and healthy household contacts of the patients","volume":"2","author":"Hussain","year":"1995","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.medcli.2010.09.008_bib0150","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1128\/CVI.00355-07","article-title":"Increased synthesis of anti-tuberculous glycolipid immunoglobulin G (IgG) and IgA with cavity formation in patients with pulmonary tuberculosis","volume":"15","author":"Mizusawa","year":"2008","journal-title":"Clin Vaccine Immunol."},{"key":"10.1016\/j.medcli.2010.09.008_bib0155","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.tube.2009.05.005","article-title":"Development and evaluation of a novel multiple-antigen ELISA for serodiagnosis of tuberculosis","volume":"89","author":"Zhang","year":"2009","journal-title":"Tuberculosis (Edinburgh, Scotland)."},{"key":"10.1016\/j.medcli.2010.09.008_bib0160","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1128\/CVI.00355-08","article-title":"Performance of purified antigens for serodiagnosis of pulmonary tuberculosis: a meta-analysis","volume":"16","author":"Steingart","year":"2009","journal-title":"Clin Vaccine Immunol."},{"key":"10.1016\/j.medcli.2010.09.008_bib0165","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/ng0902-97","article-title":"Genetics, cytokines and human infectious disease: lessons from weakly pathogenic mycobacteria and salmonellae","volume":"32","author":"Ottenhoff","year":"2002","journal-title":"Nat Genet."},{"key":"10.1016\/j.medcli.2010.09.008_bib0170","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1002\/art.11137","article-title":"Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in tuberculosis risk: a multicenter active-surveillance report","volume":"48","author":"Gomez-Reino","year":"2003","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.medcli.2010.09.008_bib0175","doi-asserted-by":"crossref","first-page":"e6984","DOI":"10.1371\/journal.pone.0006984","article-title":"Immunomodulation with recombinant interferon-gamma1b in pulmonary tuberculosis","volume":"4","author":"Dawson","year":"2009","journal-title":"PloS one."},{"key":"10.1016\/j.medcli.2010.09.008_bib0180","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1620\/tjem.220.21","article-title":"High numbers of interferon-gamma-producing T cells and low titers of anti-tuberculous glycolipid antibody in individuals with latent tuberculosis","volume":"220","author":"Guio","year":"2010","journal-title":"Tohoku J Exp Med."},{"key":"10.1016\/j.medcli.2010.09.008_bib0185","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1756-0500-2-19","article-title":"IP-10, MCP-1, MCP-2, MCP-3, and IL-1RA hold promise as biomarkers for infection with M. tuberculosis in a whole blood based T-cell assay","volume":"2","author":"Ruhwald","year":"2009","journal-title":"BMC research notes."},{"key":"10.1016\/j.medcli.2010.09.008_bib0190","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1365-2249.2009.03875.x","article-title":"Differential cytokine secretion and early treatment response in patients with pulmonary tuberculosis","volume":"156","author":"Djoba Siawaya","year":"2009","journal-title":"Clin Exp Immunol."},{"key":"10.1016\/j.medcli.2010.09.008_bib0195","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.cyto.2009.05.016","article-title":"Differential cytokine\/chemokines and KL-6 profiles in patients with different forms of tuberculosis","volume":"47","author":"Djoba Siawaya","year":"2009","journal-title":"Cytokine."},{"key":"10.1016\/j.medcli.2010.09.008_bib0200","first-page":"731","article-title":"Chemokine IP-10: an adjunct marker for latent tuberculosis infection in children","volume":"13","author":"Lighter","year":"2009","journal-title":"Int J Tuberc Lung Dis."},{"key":"10.1016\/j.medcli.2010.09.008_bib0205","doi-asserted-by":"crossref","first-page":"5488","DOI":"10.1016\/j.vaccine.2009.06.103","article-title":"Delaying BCG vaccination from birth to 10 weeks of age may result in an enhanced memory CD4 T cell response","volume":"27","author":"Kagina","year":"2009","journal-title":"Vaccine."},{"key":"10.1016\/j.medcli.2010.09.008_bib0210","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1542\/peds.2007-3618","article-title":"Latent tuberculosis diagnosis in children by using the QuantiFERON-TB Gold In-Tube test","volume":"123","author":"Lighter","year":"2009","journal-title":"Pediatrics."},{"key":"10.1016\/j.medcli.2010.09.008_bib0215","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1164\/rccm.200402-179OC","article-title":"Specific detection of tuberculosis infection: an interferon-gamma-based assay using new antigens","volume":"170","author":"Mori","year":"2004","journal-title":"Am J Respir Crit Care Med."},{"key":"10.1016\/j.medcli.2010.09.008_bib0220","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1164\/ajrccm.157.4.9704036","article-title":"Tuberculosis and race\/ethnicity in the United States: impact of socioeconomic status","volume":"157","author":"Cantwell","year":"1998","journal-title":"Am J Respir Crit. Care Med."},{"key":"10.1016\/j.medcli.2010.09.008_bib0225","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1471-2334-10-16","article-title":"Black race, sex, and extrapulmonary tuberculosis risk: an observational study","volume":"10","author":"Fiske","year":"2010","journal-title":"BMC Infect Dis."},{"key":"10.1016\/j.medcli.2010.09.008_bib0230","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s00439-009-0713-y","article-title":"NOS2A, TLR4, and IFNGR1 interactions influence pulmonary tuberculosis susceptibility in African-Americans","volume":"126","author":"Velez","year":"2009","journal-title":"Hum Genet."},{"key":"10.1016\/j.medcli.2010.09.008_bib0235","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1745-6673-1-7","article-title":"Persistently elevated T cell interferon-gamma responses after treatment for latent tuberculosis infection among health care workers in India: a preliminary report","volume":"1","author":"Pai","year":"2006","journal-title":"J Occup Med Toxicol."},{"key":"10.1016\/j.medcli.2010.09.008_bib0240","first-page":"2672","article-title":"Tuberculosis in a Swiss army training camp: contact investigation using an Interferon gamma release assay","volume":"138","author":"Kipfer","year":"2008","journal-title":"Swiss Med Wkly."},{"key":"10.1016\/j.medcli.2010.09.008_bib0245","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1157\/13121100","article-title":"Aplicaci\u00f3n cl\u00ednica de una prueba de producci\u00f3n de interfer\u00f3n gamma para el diagnostico de tuberculosis latente en poblaciones hospitalarias de riesgo","volume":"130","author":"Torres","year":"2008","journal-title":"Med Clin (Barc)."},{"key":"10.1016\/j.medcli.2010.09.008_bib0250","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S1473-3099(09)70149-5","article-title":"Rapid diagnosis of tuberculosis through the detection of mycobacterial DNA in urine by nucleic acid amplification methods","volume":"9","author":"Green","year":"2009","journal-title":"Lancet Infect Dis."},{"key":"10.1016\/j.medcli.2010.09.008_bib0255","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.trstmh.2005.04.014","article-title":"Detection of mycobacterial lipoarabinomannan with an antigen-capture ELISA in unprocessed urine of Tanzanian patients with suspected tuberculosis","volume":"99","author":"Boehme","year":"2005","journal-title":"T Roy Soc Trop Med H."},{"key":"10.1016\/j.medcli.2010.09.008_bib0260","first-page":"146","article-title":"Mycobacterium tuberculosis DNA detection in soluble fraction of urine from pulmonary tuberculosis patients","volume":"12","author":"Cannas","year":"2008","journal-title":"Int J Tuberc Lung Dis."}],"container-title":["Medicina Cl\u00ednica"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775310008845?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775310008845?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,6]],"date-time":"2019-06-06T00:31:43Z","timestamp":1559781103000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025775310008845"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10]]},"references-count":52,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["S0025775310008845"],"URL":"https:\/\/doi.org\/10.1016\/j.medcli.2010.09.008","relation":{},"ISSN":["0025-7753"],"issn-type":[{"value":"0025-7753","type":"print"}],"subject":[],"published":{"date-parts":[[2011,10]]}}}